zlacker

>>giulio+(OP)
>The share of U.S. households reporting at least one user rose from about 11% in late 2023 to more than 16% by mid-2024.

I was wondering how you could get such a high impact overall. But it seems one in 6 households are on GLP-1 drugs in the US.

In my friend circle in Germany I don't even know one single person on this stuff.

It's insane to me that so many people need these to get off the processed foods killing them in the US.

>>carlmr+B5
in europe there is a social stigma around GLP-1 drugs, a lot of people considered it cheating and lazy, so a lot of people don't dare talk about their usage

>>Raed66+e6
Or, you know, just less obese people

>>raverb+i6
We have quite a few obese people. Not as many as the US, but not few either.

>>carlmr+K6
> France [...] 2020 [...] excess weight was 47.3%, with 17% of subjects being obese

https://presse.inserm.fr/en/obesite-et-surpoids-pres-dun-fra...